Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

7,331 total articles

West Pharmaceutical Executive Executes Stock Option Exercise and Sale

West Pharmaceutical Executive Executes Stock Option Exercise and Sale

Chad Winters, the Vice President and Chief Accounting Officer at West Pharmaceutical Services Inc (NYSE: WST), has completed a series of transactions involving the company's common stock. On April 27, 2026, Mr. Winters exercised stock options to acquire 896 shares and subsequently sold those shares on the same day. This activity occurs amidst a per…

City Holding Co Executive Michael Quinlan Jr. Executes Stock Sale

City Holding Co Executive Michael Quinlan Jr. Executes Stock Sale

Michael T. Quinlan Jr., who serves as the Executive Vice President of Retail Banking at City Holding Co (NASDAQ: CHCO), recently completed a sale of company stock. The transaction, which took place on April 28, 2026, involved the sale of 1,210 shares of common stock. Each share was sold at a price point of $126.0932, resulting in a total transactio…

Kaltura Executive Executes Stock Sale Amid Recent Price Surge

Kaltura Executive Executes Stock Sale Amid Recent Price Surge

Eynav Azaria, an officer at Kaltura Inc. (NASDAQ: KLTR), has completed a sale of 70,838 shares of the company's common stock. This transaction took place on April 27, 2026, through a series of trades executed at various price points between $1.40 and $1.55 per share. The liquidation was conducted under a Rule 10b5-1 trading plan that Azaria had ori…

Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises

Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises

David Raben, the Chief Medical Officer of Bicara Therapeutics Inc. (NASDAQ: BCAX), has completed a series of transactions involving both the sale of common stock and the exercise of stock options. These moves were conducted under a pre-arranged Rule 10b5-1 trading plan established on February 12, 2025. The transaction activity occurred on April 27,…

BlackRock President Robert Kapito Executes $9.2 Million Share Sale

BlackRock President Robert Kapito Executes $9.2 Million Share Sale

Robert Kapito, who serves as both President and a Director of BlackRock, Inc. (NYSE: BLK), has completed a significant sale of company stock. On April 27, 2026, the executive disposed of common shares totaling approximately $9.23 million. This transaction occurred through a series of open market trades, reflecting a notable liquidity event for one …